These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

246 related items for PubMed ID: 21852324

  • 1. Mitogen-activated protein kinase phosphatase 1 regulates bone mass, osteoblast gene expression, and responsiveness to parathyroid hormone.
    Mahalingam CD, Datta T, Patil RV, Kreider J, Bonfil RD, Kirkwood KL, Goldstein SA, Abou-Samra AB, Datta NS.
    J Endocrinol; 2011 Nov; 211(2):145-56. PubMed ID: 21852324
    [Abstract] [Full Text] [Related]

  • 2. MKP1-dependent PTH modulation of bone matrix mineralization in female mice is osteoblast maturation stage specific and involves P-ERK and P-p38 MAPKs.
    Mahalingam CD, Sampathi BR, Sharma S, Datta T, Das V, Abou-Samra AB, Datta NS.
    J Endocrinol; 2013 Mar; 216(3):315-29. PubMed ID: 23197743
    [Abstract] [Full Text] [Related]

  • 3. Distinct roles for mitogen-activated protein kinase phosphatase-1 (MKP-1) and ERK-MAPK in PTH1R signaling during osteoblast proliferation and differentiation.
    Datta NS, Kolailat R, Fite A, Pettway G, Abou-Samra AB.
    Cell Signal; 2010 Mar; 22(3):457-66. PubMed ID: 19892016
    [Abstract] [Full Text] [Related]

  • 4. Parathyroid hormone induces mitogen-activated kinase phosphatase 1 in murine osteoblasts primarily through cAMP-protein kinase A signaling.
    Aghaloo TL, Pirih FQ, Shi A, Bezouglaia O, Tetradis S.
    J Periodontol; 2006 Jan; 77(1):21-30. PubMed ID: 16579699
    [Abstract] [Full Text] [Related]

  • 5. Anabolic effects of PTH in cyclooxygenase-2 knockout osteoblasts in vitro.
    Choudhary S, Huang H, Raisz L, Pilbeam C.
    Biochem Biophys Res Commun; 2008 Aug 08; 372(4):536-41. PubMed ID: 18501188
    [Abstract] [Full Text] [Related]

  • 6. Disruption of LRP6 in osteoblasts blunts the bone anabolic activity of PTH.
    Li C, Xing Q, Yu B, Xie H, Wang W, Shi C, Crane JL, Cao X, Wan M.
    J Bone Miner Res; 2013 Oct 08; 28(10):2094-108. PubMed ID: 23609180
    [Abstract] [Full Text] [Related]

  • 7. Parathyroid hormone-responsive Smad3-related factor, Tmem119, promotes osteoblast differentiation and interacts with the bone morphogenetic protein-Runx2 pathway.
    Hisa I, Inoue Y, Hendy GN, Canaff L, Kitazawa R, Kitazawa S, Komori T, Sugimoto T, Seino S, Kaji H.
    J Biol Chem; 2011 Mar 18; 286(11):9787-96. PubMed ID: 21239498
    [Abstract] [Full Text] [Related]

  • 8. Anabolic action of parathyroid hormone is skeletal site specific at the tissue and cellular levels in mice.
    Iida-Klein A, Zhou H, Lu SS, Levine LR, Ducayen-Knowles M, Dempster DW, Nieves J, Lindsay R.
    J Bone Miner Res; 2002 May 18; 17(5):808-16. PubMed ID: 12009011
    [Abstract] [Full Text] [Related]

  • 9. Effects of tanshinol on markers of bone turnover in ovariectomized rats and osteoblast cultures.
    Han J, Wang W.
    PLoS One; 2017 May 18; 12(7):e0181175. PubMed ID: 28746340
    [Abstract] [Full Text] [Related]

  • 10. Low-dose PTH increases osteoblast activity via decreased Mef2c/Sost in senescent osteopenic mice.
    Saidak Z, Le Henaff C, Azzi S, Marty C, Marie PJ.
    J Endocrinol; 2014 Oct 18; 223(1):25-33. PubMed ID: 25056116
    [Abstract] [Full Text] [Related]

  • 11. The PERK-EIF2α-ATF4 signaling branch regulates osteoblast differentiation and proliferation by PTH.
    Zhang K, Wang M, Li Y, Li C, Tang S, Qu X, Feng N, Wu Y.
    Am J Physiol Endocrinol Metab; 2019 Apr 01; 316(4):E590-E604. PubMed ID: 30668150
    [Abstract] [Full Text] [Related]

  • 12. Parathyroid Hormone-Related Protein Protects Osteoblastic Cells From Oxidative Stress by Activation of MKP1 Phosphatase.
    Ardura JA, Portal-Núñez S, Castelbón-Calvo I, Martínez de Toda I, De la Fuente M, Esbrit P.
    J Cell Physiol; 2017 Apr 01; 232(4):785-796. PubMed ID: 27357344
    [Abstract] [Full Text] [Related]

  • 13. Overexpression of secreted frizzled-related protein 1 inhibits bone formation and attenuates parathyroid hormone bone anabolic effects.
    Yao W, Cheng Z, Shahnazari M, Dai W, Johnson ML, Lane NE.
    J Bone Miner Res; 2010 Feb 01; 25(2):190-9. PubMed ID: 19594295
    [Abstract] [Full Text] [Related]

  • 14. gp130 in late osteoblasts and osteocytes is required for PTH-induced osteoblast differentiation.
    Standal T, Johnson RW, McGregor NE, Poulton IJ, Ho PW, Martin TJ, Sims NA.
    J Endocrinol; 2014 Nov 01; 223(2):181-90. PubMed ID: 25228504
    [Abstract] [Full Text] [Related]

  • 15. Deficiency of the G-protein alpha-subunit G(s)alpha in osteoblasts leads to differential effects on trabecular and cortical bone.
    Sakamoto A, Chen M, Nakamura T, Xie T, Karsenty G, Weinstein LS.
    J Biol Chem; 2005 Jun 03; 280(22):21369-75. PubMed ID: 15797856
    [Abstract] [Full Text] [Related]

  • 16. Role of PTH1R internalization in osteoblasts and bone mass using a phosphorylation-deficient knock-in mouse model.
    Datta NS, Samra TA, Mahalingam CD, Datta T, Abou-Samra AB.
    J Endocrinol; 2010 Dec 03; 207(3):355-65. PubMed ID: 20929987
    [Abstract] [Full Text] [Related]

  • 17. Loss of Gsα in the Postnatal Skeleton Leads to Low Bone Mass and a Blunted Response to Anabolic Parathyroid Hormone Therapy.
    Sinha P, Aarnisalo P, Chubb R, Poulton IJ, Guo J, Nachtrab G, Kimura T, Swami S, Saeed H, Chen M, Weinstein LS, Schipani E, Sims NA, Kronenberg HM, Wu JY.
    J Biol Chem; 2016 Jan 22; 291(4):1631-1642. PubMed ID: 26598522
    [Abstract] [Full Text] [Related]

  • 18. Normal epidermal growth factor receptor signaling is dispensable for bone anabolic effects of parathyroid hormone.
    Schneider MR, Dahlhoff M, Andrukhova O, Grill J, Glösmann M, Schüler C, Weber K, Wolf E, Erben RG.
    Bone; 2012 Jan 22; 50(1):237-44. PubMed ID: 22056328
    [Abstract] [Full Text] [Related]

  • 19. CREM deficiency in mice alters the response of bone to intermittent parathyroid hormone treatment.
    Liu F, Lee SK, Adams DJ, Gronowicz GA, Kream BE.
    Bone; 2007 Apr 22; 40(4):1135-43. PubMed ID: 17275432
    [Abstract] [Full Text] [Related]

  • 20. Atorvastatin promotes bone formation in aged apoE-/- mice through the Sirt1-Runx2 axis.
    Hong W, Wei Z, Qiu Z, Li Z, Fu C, Ye Z, Xu X.
    J Orthop Surg Res; 2020 Aug 06; 15(1):303. PubMed ID: 32762716
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.